BIOMAT Database Logo BIOMAT Database Logo

[Treatment of sclerotic macular dystrophy]. 1978

L E Smidovich

UI MeSH Term Description Entries
D008268 Macular Degeneration Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms. Maculopathy,Maculopathy, Age-Related,Age-Related Macular Degeneration,Age-Related Maculopathies,Age-Related Maculopathy,Macular Degeneration, Age-Related,Macular Dystrophy,Maculopathies, Age-Related,Age Related Macular Degeneration,Age Related Maculopathies,Age Related Maculopathy,Age-Related Macular Degenerations,Degeneration, Macular,Dystrophy, Macular,Macular Degeneration, Age Related,Macular Degenerations,Macular Dystrophies,Maculopathies,Maculopathy, Age Related
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012598 Sclerosis A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve. Scleroses
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L E Smidovich
[Relationship between general state of the body and clinical course of sclerotic macular dystrophy].
June 1976, Vrachebnoe delo,
L E Smidovich
Congenital, hypotonic-sclerotic muscular dystrophy.
December 1977, Journal of medical genetics,
L E Smidovich
[Taufon and emoksipin in the combined treatment of sclerotic macular dystrophies].
January 1989, Oftalmologicheskii zhurnal,
L E Smidovich
[Retinal function under conditions of artificial illumination with varying spectral makeup in patients with sclerotic macular dystrophy].
January 1990, Oftalmologicheskii zhurnal,
L E Smidovich
[Management and prevention of sclerotic macular degeneration].
December 1967, Deutsche medizinische Wochenschrift (1946),
L E Smidovich
[Congenital atonic-sclerotic muscular dystrophy (Ullrich disease)].
January 1991, Neurologia (Barcelona, Spain),
L E Smidovich
[Congenital atonic-sclerotic muscular dystrophy (Ullrich type)].
January 1954, Zeitschrift fur Kinderheilkunde,
L E Smidovich
[Sorsby's pseudo-inflammatory macular dystrophy: laser treatment].
January 1989, Journal francais d'ophtalmologie,
L E Smidovich
[Dicinon in the treatment of arteriosclerotic macular dystrophy].
January 1980, Oftalmologicheskii zhurnal,
L E Smidovich
Autosomal dominant macular dystrophy simulating North Carolina macular dystrophy.
February 1995, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!